Sophie L’helias Acquires 1,200 Shares of Herbalife (NYSE:HLF) Stock

Herbalife Ltd (NYSE:HLFGet Free Report) Director Sophie L’helias acquired 1,200 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were acquired at an average cost of $11.31 per share, with a total value of $13,572.00. Following the transaction, the director directly owned 79,882 shares in the company, valued at $903,465.42. The trade was a 1.53% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.

Herbalife Price Performance

Shares of NYSE HLF traded up $0.00 during trading hours on Thursday, hitting $11.39. 1,393,000 shares of the company’s stock were exchanged, compared to its average volume of 1,536,295. Herbalife Ltd has a 1-year low of $7.43 and a 1-year high of $20.40. The stock has a market capitalization of $1.18 billion, a price-to-earnings ratio of 5.00, a PEG ratio of 0.71 and a beta of 0.88. The company’s 50-day moving average price is $14.43 and its 200-day moving average price is $14.82.

Herbalife (NYSE:HLFGet Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.61 by $0.03. The business had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.30 billion. Herbalife had a negative return on equity of 41.47% and a net margin of 4.67%.The firm’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.59 EPS. On average, research analysts expect that Herbalife Ltd will post 2.47 earnings per share for the current year.

Hedge Funds Weigh In On Herbalife

A number of hedge funds have recently modified their holdings of the stock. Arrowstreet Capital Limited Partnership raised its holdings in shares of Herbalife by 11.5% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,596,795 shares of the company’s stock worth $38,225,000 after buying an additional 267,539 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Herbalife by 1.0% in the 4th quarter. Geode Capital Management LLC now owns 2,577,634 shares of the company’s stock worth $33,231,000 after buying an additional 25,783 shares in the last quarter. Quantedge Capital Pte Ltd raised its holdings in shares of Herbalife by 5.2% in the 4th quarter. Quantedge Capital Pte Ltd now owns 2,249,683 shares of the company’s stock worth $28,998,000 after buying an additional 111,700 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Herbalife by 29.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,877,717 shares of the company’s stock worth $27,638,000 after buying an additional 425,968 shares in the last quarter. Finally, Solel Partners LP raised its holdings in shares of Herbalife by 18.7% in the 2nd quarter. Solel Partners LP now owns 1,669,405 shares of the company’s stock worth $14,390,000 after buying an additional 262,614 shares in the last quarter.

Wall Street Analyst Weigh In

HLF has been the subject of several recent research reports. Wall Street Zen raised Herbalife from a “buy” rating to a “strong-buy” rating in a report on Saturday, April 18th. Zacks Research cut Herbalife from a “strong-buy” rating to a “hold” rating in a report on Monday, April 20th. Royal Bank Of Canada cut their price target on Herbalife from $17.00 to $16.00 and set a “sector perform” rating for the company in a report on Tuesday, April 28th. Citigroup reaffirmed a “buy” rating and issued a $21.00 price target (up from $17.00) on shares of Herbalife in a report on Thursday, February 19th. Finally, Weiss Ratings cut Herbalife from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 22nd. Three equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $17.80.

Check Out Our Latest Stock Analysis on HLF

About Herbalife

(Get Free Report)

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.

Featured Articles

Insider Buying and Selling by Quarter for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.